Deflazacort in Dysferlinopathies

NCT00527228 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

LGMD2B
Miyoshi Myopathy
Dysferlinopathy

Interventions

DRUG: deflazacort
DRUG: placebo

Sponsor

Ludwig-Maximilians - University of Munich